Apple's New Patent Approved: Mapping Body Data Based on CGR Technology to Display Clothing Wearing Effects
红花少年压
发表于 2023-11-9 10:39:34
1292
0
0
According to a list published by the United States Trademark and Patent Office (USPTO), Apple has obtained a technology patent that describes an application based on computer generated reality (CGR) technology to improve users' purchasing experience. According to the patent description, Apple introduced a sales application suitable for iPhone, iPad, Mac, and Vision Pro, which uses CGR technology to generate a virtual image of the buyer and then displays the wearing effect of T-shirts, jerseys, or other items.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Tesla Musk: Expected FSD to be approved and implemented in China before the end of the year
- The Class 1 new drug introduced by Anjin with over 1 billion US dollars has been approved for clinical use
- JD Allianz Equity Transfer Approved: Allianz Insurance Group to Transfer 53.33% Equity of the Company to Allianz China Holdings
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
- Johnson&Johnson's drug Zebaike has been approved in China
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Multiple new indications for Merck drugs approved for market in China
- BeiGene and BeiZeAn are approved for new indications in the United States